Ekachai Medical Care Public Company Limited (EKH.BK)
THB 6.25
(0.81%)
THB 6.25
(0.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.2 Billion | 1.04 Billion | 1.14 Billion | 645.75 Million | 886.04 Million | 638.12 Million |
| Cost of Revenue | 681.54 Million | 609 Million | 602.78 Million | 447.31 Million | 509.33 Million | 382.14 Million |
| Gross Profit | 527.06 Million | 439.5 Million | 543.57 Million | 198.43 Million | 376.7 Million | 255.97 Million |
| Operating Expenses | 174.3 Million | 179.78 Million | 162.75 Million | 120.09 Million | 195.04 Million | 128.42 Million |
| Selling, General and Administrative Expenses | 223.89 Million | 197.33 Million | 173.05 Million | 133.07 Million | 195.04 Million | 128.42 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -49.59 Million | -17.55 Million | -10.29 Million | -12.98 Million | 24.95 Million | 16.16 Million |
| Cost and Expenses | 843.52 Million | 788.78 Million | 765.54 Million | 567.4 Million | 704.37 Million | 510.56 Million |
| Operating Income | 365.08 Million | 262.08 Million | 425.19 Million | 81.15 Million | 206.62 Million | 127.55 Million |
| Interest Expense | 1.65 Million | 1.61 Million | 1.8 Million | 1.55 Million | 1446.00 | 285.00 |
| Income Tax Expense | 70.58 Million | 134.86 Million | 84.24 Million | 13.81 Million | 40.53 Million | 26.28 Million |
| Earnings before Tax | 372.86 Million | 685.74 Million | 424.75 Million | 79.59 Million | 206.61 Million | 143.72 Million |
| Net Income | 297.26 Million | 551.32 Million | 344.83 Million | 72.1 Million | 160.29 Million | 117.2 Million |
| Earnings Per Share Basic | 0.43 | 0.84 | 0.54 | 0.11 | 0.25 | 0.18 |
| Earnings Per Share Diluted | 0.40 | 0.80 | 0.54 | 0.11 | 0.25 | 0.18 |
| Weighted Average Shares Outstanding | 697.26 Million | 660.16 Million | 636.73 Million | 637.92 Million | 639.6 Million | 639.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 734.17 Million | 693.2 Million | 640.52 Million | 637.92 Million | 639.6 Million | 639.6 Million |
| Gross Margin | 0.44 | 0.42 | 0.47 | 0.31 | 0.43 | 0.40 |
| EBIT Margin | 0.38 | 0.32 | 0.40 | 0.23 | 0.29 | 0.28 |
| Profit Margin | 0.25 | 0.53 | 0.30 | 0.11 | 0.18 | 0.18 |
| EBITDA | 460.24 Million | 763.85 Million | 501.65 Million | 150.61 Million | 253.54 Million | 178.23 Million |
| Earnings Before Tax Margin | 0.30 | 0.25 | 0.37 | 0.13 | 0.23 | 0.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 310.64 Million | 319.07 Million | 1.2 Billion | 316.12 Million | 332.73 Million | 298.71 Million |
| Cost of Revenue | 177.78 Million | 175.92 Million | 681.54 Million | 174.85 Million | 177.64 Million | 166.33 Million |
| Gross Profit | 132.86 Million | 143.15 Million | 527.06 Million | 141.27 Million | 155.08 Million | 132.37 Million |
| Operating Expenses | 68.43 Million | 87.48 Million | 211.57 Million | 41.74 Million | 57.22 Million | 112.96 Million |
| Selling, General and Administrative Expenses | 68.43 Million | 87.48 Million | - | 41.74 Million | 57.22 Million | 112.96 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 11.78 Million | 3.1 Million | 13.29 Million | -13.54 Million | 15.97 Million | 11.72 Million |
| Cost and Expenses | 246.21 Million | 263.41 Million | 893.12 Million | 216.59 Million | 234.86 Million | 279.3 Million |
| Operating Income | 64.43 Million | 55.66 Million | 315.48 Million | 99.53 Million | 113.84 Million | 31.13 Million |
| Interest Expense | 503 Thousand | 525 Thousand | 1.65 Million | 363.16 Thousand | 397 Thousand | 430 Thousand |
| Income Tax Expense | 16.52 Million | 4.7 Million | 70.58 Million | 24.48 Million | 21.07 Million | 5.21 Million |
| Earnings before Tax | 81.25 Million | 63.24 Million | 372.86 Million | 125.08 Million | 115.92 Million | 32.81 Million |
| Net Income | 62.31 Million | 55.64 Million | 297.26 Million | 99.66 Million | 93.16 Million | 26.09 Million |
| Earnings Per Share Basic | 0.08 | 0.07 | - | 0.14 | 0.13 | 0.04 |
| Earnings Per Share Diluted | 0.08 | 0.07 | - | 0.14 | 0.13 | 0.04 |
| Weighted Average Shares Outstanding | 744.75 Million | 746.14 Million | 697.26 Million | 701.27 Million | 699.5 Million | 674.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 771.27 Million | 775.58 Million | 734.17 Million | 733.72 Million | 737.45 Million | 694.4 Million |
| Gross Margin | 0.43 | 0.45 | 0.44 | 0.45 | 0.47 | 0.44 |
| EBIT Margin | 0.34 | 0.24 | - | 0.39 | 0.42 | 0.18 |
| Profit Margin | 0.20 | 0.17 | 0.25 | 0.32 | 0.28 | 0.09 |
| EBITDA | 104.3 Million | 77.85 Million | - | 121.93 Million | 138.36 Million | 54.24 Million |
| Earnings Before Tax Margin | 0.21 | 0.17 | 0.26 | 0.31 | 0.34 | 0.10 |
3611
PGM
AAREYDRUGS
PPPM
6724
JUBLPHARMA